Abstract
Conformationally constrained cis-amide chimeric inhibitors of Hsp90 have been synthesized and evaluated for their Hsp90 inhibitory activity. These new compounds exhibited Hsp90 ATPase inhibition and induced Hsp90-dependent client protein degradation in a dose-dependent manner. Biological data reported herein suggests that amide bond isomerization of geldanamycin derivatives plays an important role in affinity for the heteroprotein complex present in cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 2353-2356 |
Number of pages | 4 |
Journal | Organic Letters |
Volume | 11 |
Issue number | 11 |
DOIs | |
State | Published - Jun 4 2009 |
Externally published | Yes |